Inozyme Pharma, Inc.
INZY
$1.26
-$0.23-15.44%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -40.04% | -31.61% | 3.05% | 26.90% | 47.49% |
| Total Receivables | 21.30% | -- | -- | -- | 234.78% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -6.39% | 10.87% | 152.59% | 153.92% | 113.25% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -38.51% | -29.83% | 6.53% | 29.95% | 49.36% |
|
|
|||||
| Total Current Assets | -38.51% | -29.83% | 6.53% | 29.95% | 49.36% |
| Net Property, Plant & Equipment | -48.07% | -41.73% | -37.49% | -33.75% | -28.75% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -42.14% | -61.67% | -81.57% | -92.53% | -51.85% |
| Total Assets | -38.67% | -30.31% | 3.17% | 24.79% | 44.29% |
|
|
|||||
| Total Accounts Payable | 116.98% | 10.17% | 75.12% | 19.34% | -54.17% |
| Total Accrued Expenses | 26.51% | 23.32% | 20.10% | -6.26% | 11.05% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1,593.96% | 415.01% | 11.25% | 11.32% | 11.52% |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 130.82% | 49.44% | 28.64% | -1.39% | -0.20% |
|
|
|||||
| Total Current Liabilities | 130.82% | 49.44% | 28.64% | -1.39% | -0.20% |
| Long-Term Debt | -29.73% | 31.19% | 42.21% | 85.94% | 981.64% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -85.73% | -69.59% | -58.27% | -49.92% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 8.26% | 33.16% | 35.19% | 51.13% | 190.22% |
|
|
|||||
| Common Stock & APIC | 4.54% | 4.43% | 21.95% | 27.62% | 27.90% |
| Retained Earnings | -35.68% | -36.50% | -35.75% | -33.21% | -33.14% |
| Treasury Stock & Other | 68.29% | 338.46% | -301.96% | -191.67% | 120.00% |
| Total Common Equity | -58.84% | -48.33% | -10.58% | 14.99% | 18.65% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -58.84% | -48.33% | -10.58% | 14.99% | 18.65% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -58.84% | -48.33% | -10.58% | 14.99% | 18.65% |
|
|
|||||